The objective of this article is to provide health care providers, patients, and the general public with a responsible assessment of current available methods to diagnose, treat, and manage hepatitis C. A non-Federal, non-advocate, 12-member panel representing the fields of general internal medicine
National Institutes of Health consensus development conference statement: Management of hepatitis B
โ Scribed by Michael F. Sorrell; Edward A. Belongia; Jose Costa; Ilana F. Gareen; Jean L. Grem; John M. Inadomi; Earl R. Kern; James A. McHugh; Gloria M. Petersen; Michael F. Rein; Doris B. Strader; Hartwell T. Trotter
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 153 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
That conference was prompted by the uncertainty and confusion that surrounded the issues of the natural history, diagnosis, management, and particularly treatment of hepatitis C. At the time, the only available treatment for hepatitis C was monotherapy with interferon alfa. Overall, response rates t
of Health (NIH) Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma, held in June 1990, recommended breast conservation therapy for the majority of women with Stage I or II breast carcinoma. The authors evaluated the national use of breast conserv